Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares The 2021 WHO classification of tumours of the central nervous system: a summary, CDKN2A/B homozygous deletion, Active surveillance, DNA methylation profiling and the tags subtype-page, cns.
Shares The 2021 WHO classification of tumours of the central nervous system: a summary, CDKN2A/B homozygous deletion, Active surveillance, DNA methylation profiling and the tags subtype-page, cns.
Shares The 2021 WHO classification of tumours of the central nervous system: a summary, Craniopharyngioma, Pituitary tumours (pituitary neuroendocrine tumours) and pituitary carcinoma, Brain and spinal cord tumours (all types) and the tags subtype-page, cns.
Shares The 2021 WHO classification of tumours of the central nervous system: a summary, CDKN2A/B homozygous deletion, DNA methylation profiling, Brain and spinal cord tumours (all types) and the tags subtype-page, cns.
Shares The 2021 WHO classification of tumours of the central nervous system: a summary, DNA methylation profiling, Proton therapy, Bevacizumab and the tags subtype-page, cns.
Shares The 2021 WHO classification of tumours of the central nervous system: a summary, DNA methylation profiling, Proton therapy, IMRT / IGRT (modern external beam) and the tags subtype-page, cns.
Shares The 2021 WHO classification of tumours of the central nervous system: a summary, DNA methylation profiling, Proton therapy, IMRT / IGRT (modern external beam) and the tags subtype-page, cns.
Shares mTOR, Active surveillance, Everolimus, MRI and the tag subtype-page.
The same record for scripts and assistants; checked 2026-09-17. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.